Loading Events
  • This event has passed.

Roundup of J.P. Morgan’s Annual Healthcare Conference

Roundup of J.P. Morgan’s Annual Healthcare Conference

BiotechFinances and Neighborhood are pleased to invite you to the first edition of the BiotechScope® 2019 in the prestigious setting of the Neighborhood, VCLS’s Innovation Center. Back from the 36th JP Morgan Healthcare conference in San Francisco, the editorial staff of BiotechFinances, the only French-speaking professional media company that has attended this event for two years offers you:

  • Roundtable talks on “prospective biotechs 2019”  led by Pierre-Louis Germain, editor-in-chief of BiotechFinances, with key industrial and financial players at this major annual meeting, which sets out the year’s main trends in financing and development of the sector.
  • Discover the 2019 vintage of BioMap France, a map of French biotech published since 1994 by Biotech Finances and the Special Deal issues of autumn.

Event language: French

About the Speakers :

Antoine Papiernik Managing partner and president of Sofinnova Partners An associate partner since 1997, Antoine Papiernik holds an MBA from the Wharton School. He started his career at Unilever, before becoming Director of Investments at CDC Innovation (now Bpifrance).  

 

 

Marc Le Bozec Fund Manager Pluvalca Biotech A graduate from HEC, Marc le Bozec was chief financial officer of Cellectis from 2006 to 2013 then CEO of Cytoo from 2013 to 2015. He launched Pluvalca Biotech in 2014 with Sébastien Lalevée( CEO of Financière Arbevel). This fund is still the only investment vehicle exclusively dedicated to listed European biotech companies.

 

  Judith Greciet CEO of Onxeo CEO of Onxeo since 2011, Judith Greciet is a doctor in pharmacy. She spent her entire career in the industry at Pharmacia, Zeneca, LFB, Wyeth and Eisai, where she managed the French subsidiary from 2007 till 2011.

 

 

  Gérard Soula CEO of Adocia President and CEO of Adocia Gérard Soula founded Adocia in December 2005, with his two sons, Olivier and Rémi. These three highly skilled scientists each have a PhD degree in polymer science. Based on this expertise, they have designed innovative protein formulations for regenerative medicine and chronic disease.